Skip to main content
Top
Published in: The journal of nutrition, health & aging 10/2020

01-12-2020 | Sarcopenia | Editorial

Physical Frailty: A Biological Marker of Aging?

Author: John E. Morley

Published in: The journal of nutrition, health & aging | Issue 10/2020

Login to get access

Excerpt

Intrinsic capacity is defined as the resilience that an individual has to overcome a variety of environmental, physical and psychological factors (1). A person’s intrinsic capacity is created by their genes and a number of life style factors, e.g., exercise and diet, health care, e.g., vaccines and environmental. Intrinsic capacity tends to peak between 30 to 40 years, after which it slowly declines (2) (Figure 1). Frailty is defined when a person declines at a more rapid rate than that normally seen with the decline in age-related intrinsic capacity. Frail persons are at a greater risk of decline when exposed to stressors (3). In modern geriatrics frailty is interpreted as being a transitional process between a resident individual and one with disability (4, 5).
Literature
2.
go back to reference Morley JE. Editorial: Geriatrics: Highlights of the last 50 years. J Nutr Health Aging 2019;23:910–913.PubMedCrossRef Morley JE. Editorial: Geriatrics: Highlights of the last 50 years. J Nutr Health Aging 2019;23:910–913.PubMedCrossRef
3.
go back to reference Dent E, Morley JE, Cruz-Jentoft AJ, et al. Physical frailty: ICFSR International clinical practice guidelines for identification and management. J Nutr Health Aging 2019;23:771–787.PubMedPubMedCentralCrossRef Dent E, Morley JE, Cruz-Jentoft AJ, et al. Physical frailty: ICFSR International clinical practice guidelines for identification and management. J Nutr Health Aging 2019;23:771–787.PubMedPubMedCentralCrossRef
4.
go back to reference Dent E, Lien C, Lim WS, et al. The Asia-Pacific clinical guidelines for the management of frailty. J Am Med Dir Assoc 2017;18:564–575.PubMedCrossRef Dent E, Lien C, Lim WS, et al. The Asia-Pacific clinical guidelines for the management of frailty. J Am Med Dir Assoc 2017;18:564–575.PubMedCrossRef
6.
go back to reference Fried LP, Tangen CM, Walston J, et al Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: Evidence for a phenotype. J Gerontol A biol Sci Med Sci 2001;56:M146–M156.PubMedCrossRef Fried LP, Tangen CM, Walston J, et al Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: Evidence for a phenotype. J Gerontol A biol Sci Med Sci 2001;56:M146–M156.PubMedCrossRef
7.
go back to reference Malmstrom TK, Miller DK, Morley JE. A comparison of four frailty models. J Am Geriatr Soci 2014;62:721–726.CrossRef Malmstrom TK, Miller DK, Morley JE. A comparison of four frailty models. J Am Geriatr Soci 2014;62:721–726.CrossRef
8.
go back to reference Rockwood K, Song X, MacKnight C, et al A global clinical measure of fitness and frailty in elderly people. CMAJ 2005;175:489–495.CrossRef Rockwood K, Song X, MacKnight C, et al A global clinical measure of fitness and frailty in elderly people. CMAJ 2005;175:489–495.CrossRef
10.
go back to reference Kelaiditi E, Cesari M, Canevelli M, et al. Cognitive frailty: Rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. J Nutr Health Aging 2013;17:726–734.PubMedCrossRef Kelaiditi E, Cesari M, Canevelli M, et al. Cognitive frailty: Rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group. J Nutr Health Aging 2013;17:726–734.PubMedCrossRef
11.
go back to reference Kwan RYC, Leung AYM, Yee A, et al. Cognitive frailty and its association with nutrition and depression in community-dwelling older people. Kwan RYC, Leung AYM, Yee A, et al. Cognitive frailty and its association with nutrition and depression in community-dwelling older people.
12.
go back to reference Tseng SH, Liu LK, Peng LN, et al. Development and validation of a tool to screen for cognitive frailty among community-dwelling elders. J Nutr Health Aging 2019;23:904–909.PubMedCrossRef Tseng SH, Liu LK, Peng LN, et al. Development and validation of a tool to screen for cognitive frailty among community-dwelling elders. J Nutr Health Aging 2019;23:904–909.PubMedCrossRef
13.
14.
go back to reference Dent E, Morley JE, Cruz-Jentoft AJ, et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, diagnosis and management. J Nutr Health Aging 2018;22:1148–1161.CrossRefPubMed Dent E, Morley JE, Cruz-Jentoft AJ, et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, diagnosis and management. J Nutr Health Aging 2018;22:1148–1161.CrossRefPubMed
15.
go back to reference Ha YC, Won Won C, Kim M, Chun KJ, Yoo JI. SARC-F as a useful tool for screening sarcopenia in elderly patients with hip fractures. J Nutr Health Aging 2020;24:78–82.CrossRefPubMed Ha YC, Won Won C, Kim M, Chun KJ, Yoo JI. SARC-F as a useful tool for screening sarcopenia in elderly patients with hip fractures. J Nutr Health Aging 2020;24:78–82.CrossRefPubMed
16.
go back to reference Sanchez-Rodriguez D, Marco E, Davalos-Yerovi V, et al. Translation and validation of the Spanish version of the SARC-F questionnaire to assess sarcopenia in older people. J Nutr Health Aging 2019;23:518–524.PubMedCrossRef Sanchez-Rodriguez D, Marco E, Davalos-Yerovi V, et al. Translation and validation of the Spanish version of the SARC-F questionnaire to assess sarcopenia in older people. J Nutr Health Aging 2019;23:518–524.PubMedCrossRef
17.
go back to reference Malmstrom TK, Miller DK, Simonsick EM, et al. SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 2016;7:28–36.CrossRefPubMed Malmstrom TK, Miller DK, Simonsick EM, et al. SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 2016;7:28–36.CrossRefPubMed
20.
go back to reference Morley JE, Perry HM 3rd. The management of diabetes mellitus in older individuals. Drugs 1991;41:548–565.PubMedCrossRef Morley JE, Perry HM 3rd. The management of diabetes mellitus in older individuals. Drugs 1991;41:548–565.PubMedCrossRef
21.
go back to reference Scherrer JF, Salas J, Floyd JS, et al. Metformin and sulfonylurea use and risk of incident dementia. Mayo Clin Proc 2019;94:1444–1456.PubMedCrossRef Scherrer JF, Salas J, Floyd JS, et al. Metformin and sulfonylurea use and risk of incident dementia. Mayo Clin Proc 2019;94:1444–1456.PubMedCrossRef
22.
go back to reference Farr SA, Roesler E, Niehoff ML, et al. Metformin improves learning and memory in the SAMP8 mouse model of Alzheimer’s disease. J Alzheimers Dis 2019;68:1699–1710.PubMedCrossRef Farr SA, Roesler E, Niehoff ML, et al. Metformin improves learning and memory in the SAMP8 mouse model of Alzheimer’s disease. J Alzheimers Dis 2019;68:1699–1710.PubMedCrossRef
25.
go back to reference Verreault R, Laurin D, Lindsay J, de Serres G. Past exposure to vaccines and subsequent risk of Alzheimer’s disease. CMAJ 2001;165:1495–1498.PubMedPubMedCentral Verreault R, Laurin D, Lindsay J, de Serres G. Past exposure to vaccines and subsequent risk of Alzheimer’s disease. CMAJ 2001;165:1495–1498.PubMedPubMedCentral
26.
go back to reference Cardosa AL, Fernandes A, Aguilar-Pimentel JA, et al. Towards frailty biomarkers; candidates from genes and pathways regulated in aging and age-related diseases. Ageing Res Rev 2018;47:214–277.CrossRef Cardosa AL, Fernandes A, Aguilar-Pimentel JA, et al. Towards frailty biomarkers; candidates from genes and pathways regulated in aging and age-related diseases. Ageing Res Rev 2018;47:214–277.CrossRef
28.
30.
go back to reference Leng SX, Xue QL, Tian J, Walston JD, Fried LP. Inflammation and frailty in older women. J Am Geriatr Soc 2007;55:864–871.PubMedCrossRef Leng SX, Xue QL, Tian J, Walston JD, Fried LP. Inflammation and frailty in older women. J Am Geriatr Soc 2007;55:864–871.PubMedCrossRef
32.
go back to reference Woo J, Leung J, Morley JE. Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation. J Am Geriatr Soc 2012;60:1478–1486.PubMedCrossRef Woo J, Leung J, Morley JE. Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation. J Am Geriatr Soc 2012;60:1478–1486.PubMedCrossRef
33.
go back to reference Ma L. Current situation of frailty screening tools for older adults. J Nutr Health Aging 2019;23:111–118.PubMedCrossRef Ma L. Current situation of frailty screening tools for older adults. J Nutr Health Aging 2019;23:111–118.PubMedCrossRef
34.
go back to reference Aprahamian I, Arico de Almeida GV, de Vasconcellos Romanin CF, et al. Frailty could predict death in older adults after admission at Emergency department? A 6-month prospective study from a middle-income country. J Nutr Health Aging 2019;23:641–647.PubMedCrossRef Aprahamian I, Arico de Almeida GV, de Vasconcellos Romanin CF, et al. Frailty could predict death in older adults after admission at Emergency department? A 6-month prospective study from a middle-income country. J Nutr Health Aging 2019;23:641–647.PubMedCrossRef
35.
go back to reference Yu R, So MC, Tong C, Ho F, Woo J. Older adults’ perspective towards participation in a multicomponent frailty prevention program: A qualitative study. J Nutr Health Aging 2020;24:758–764.PubMedCrossRef Yu R, So MC, Tong C, Ho F, Woo J. Older adults’ perspective towards participation in a multicomponent frailty prevention program: A qualitative study. J Nutr Health Aging 2020;24:758–764.PubMedCrossRef
37.
go back to reference Sadjapoing U, Yodkeeree S, Sungkarat S, Siviroj P. Multicomponent exercise program reduces frailty and inflammatory biomarkers and improves physical performance in community-dwelling older adults: A randomized controlled trial. Int J Environ Res Public Health 2020;17:3760. Doi: https://doi.org/10.3390/ijerph17113760.CrossRef Sadjapoing U, Yodkeeree S, Sungkarat S, Siviroj P. Multicomponent exercise program reduces frailty and inflammatory biomarkers and improves physical performance in community-dwelling older adults: A randomized controlled trial. Int J Environ Res Public Health 2020;17:3760. Doi: https://​doi.​org/​10.​3390/​ijerph17113760.CrossRef
38.
go back to reference Ribero SML, Morley JE, Malmstrom TK, Miller DK. Fruit and vegetable intake and physical activity as predictors of disability risk factors in African-American middle-aged individuals. J Nutr Health Aging 2016;20:891–896.CrossRef Ribero SML, Morley JE, Malmstrom TK, Miller DK. Fruit and vegetable intake and physical activity as predictors of disability risk factors in African-American middle-aged individuals. J Nutr Health Aging 2016;20:891–896.CrossRef
39.
go back to reference Gao J, Jia Y, Dai J, et al. Association of fruit and vegetable intake and frailty among Chinese elders: A cross-sectional study in three cities. J Nutr Health Aging 2019;23:890–895.PubMedCrossRef Gao J, Jia Y, Dai J, et al. Association of fruit and vegetable intake and frailty among Chinese elders: A cross-sectional study in three cities. J Nutr Health Aging 2019;23:890–895.PubMedCrossRef
40.
go back to reference Martinez-Lapiscina EH, Clavero P, Toledo E, et al. Virgin olive oil supplementation and long-term cognition: The PREDIMED-NAVARRA randomized, trial. J Nutr Health Aging 2013;17:544–552.PubMedCrossRef Martinez-Lapiscina EH, Clavero P, Toledo E, et al. Virgin olive oil supplementation and long-term cognition: The PREDIMED-NAVARRA randomized, trial. J Nutr Health Aging 2013;17:544–552.PubMedCrossRef
41.
go back to reference Farr SA, Price TO, Domiguez LJ, et al. Extra virgin olive oil improves learning and memory in SAMP8 mice. J Alzheimers Dis 2012;28:81–92.PubMedCrossRef Farr SA, Price TO, Domiguez LJ, et al. Extra virgin olive oil improves learning and memory in SAMP8 mice. J Alzheimers Dis 2012;28:81–92.PubMedCrossRef
42.
43.
go back to reference Morley JE. Rapid geriatric assessment: Secondary prevention to stop age-associated disability. Clin Geriatr Med 2017;33:431–440.PubMedCrossRef Morley JE. Rapid geriatric assessment: Secondary prevention to stop age-associated disability. Clin Geriatr Med 2017;33:431–440.PubMedCrossRef
44.
go back to reference Morley JE. Frailty and sarcopenia: The new geriatrics giants. Rev Invest Clin 2016;68:59–67.PubMed Morley JE. Frailty and sarcopenia: The new geriatrics giants. Rev Invest Clin 2016;68:59–67.PubMed
45.
go back to reference Jadczak AD, Visvanathan R. Anorexia of aging — an updated short review. J Nutr Health Aging 2019;23:306–309.PubMedCrossRef Jadczak AD, Visvanathan R. Anorexia of aging — an updated short review. J Nutr Health Aging 2019;23:306–309.PubMedCrossRef
46.
go back to reference Morley JE, Vellas B. Patient-centered (P4) medicine and the older person. J AM Med Dir Assoc 2017;18:455–459.PubMedCrossRef Morley JE, Vellas B. Patient-centered (P4) medicine and the older person. J AM Med Dir Assoc 2017;18:455–459.PubMedCrossRef
47.
go back to reference Tarazona-Santabalbina FJ, Gomez-Cabrera MC, Perez-Ros P, et al. A multicomponent exercise intervention that reverses frailty and improves cognition, emotion, and social networking in the community-dwelling frail elderly: A randomized clinical trial. J Am Med Dir Assoc 2016;17:426–433.PubMedCrossRef Tarazona-Santabalbina FJ, Gomez-Cabrera MC, Perez-Ros P, et al. A multicomponent exercise intervention that reverses frailty and improves cognition, emotion, and social networking in the community-dwelling frail elderly: A randomized clinical trial. J Am Med Dir Assoc 2016;17:426–433.PubMedCrossRef
48.
go back to reference Ge M, Zhang Y, Zhao W, et al. Prevalence and its associated factors of physical frailty and cognitive impairment: Findings from the West China Health and Aging Trend Study (WCHAT). J Nutr Health Aging 2020;24:525–533.PubMedCrossRef Ge M, Zhang Y, Zhao W, et al. Prevalence and its associated factors of physical frailty and cognitive impairment: Findings from the West China Health and Aging Trend Study (WCHAT). J Nutr Health Aging 2020;24:525–533.PubMedCrossRef
49.
go back to reference Ruan Q, Xiao F, Gong K, et al. Prevalence of cognitive frailty phenotypes and associated factors in a community-dwelling elderly population. J Nutr Health Aging 2020;24:172–180.PubMedCrossRef Ruan Q, Xiao F, Gong K, et al. Prevalence of cognitive frailty phenotypes and associated factors in a community-dwelling elderly population. J Nutr Health Aging 2020;24:172–180.PubMedCrossRef
Metadata
Title
Physical Frailty: A Biological Marker of Aging?
Author
John E. Morley
Publication date
01-12-2020
Publisher
Springer Paris
Published in
The journal of nutrition, health & aging / Issue 10/2020
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-020-1531-0

Other articles of this Issue 10/2020

The journal of nutrition, health & aging 10/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.